Ribosome-inactivating protein (RIP)-containing
immunotoxins are currently used in clinical trials as anti-tumour drugs, in particular against haematological
malignancies. In cell killing-based
therapies it is important to identify the death pathways induced by the
cytotoxic agent. The purpose of this work was to compare the pathways of cell death induced by the RIP
saporin with those carried out by
ricin in the L540 human
Hodgkin's lymphoma-derived cell line.
Protein synthesis inhibition, activation of
caspases, DNA fragmentation and loss of viability have been evaluated. The two toxins triggered a similar DNA fragmentation and cell death, at concentrations giving the same level of cell
protein synthesis inhibition, although the inhibitory effect of
ricin on
protein synthesis was more rapid than that of
saporin. Moreover, the intrinsic apoptotic pathway was equally activated by both toxins, whilst
ricin activated the extrinsic
caspase pathway and the effector
caspase-3/7 more efficiently than
saporin. The complete inhibition of
caspases by Z-VAD was only partially effective in cell rescue which appeared to be time limited.
Necrostatin-1, a new inhibitor of non-apoptotic death, rescued cells from death by RIPs, although the effect was also partial and temporary. Despite the high RIP doses used no
necrosis was detectable by
Annexin V/
Propidium Iodide (PI) test. These results suggest that more than one death mechanism was elicited by both
ricin and
saporin, however, with different timing and strength. The perspective of modulating cell death of neoplastic lymphocytes through different pathways could add new opportunities to reduce side effects and develop combined synergic immuno-
chemotherapy.